Septerna (NASDAQ:SEPN) Trading Up 6.1% – Here’s What Happened

Septerna, Inc. (NASDAQ:SEPN)’s share price traded up 6.1% on Friday . The company traded as high as $32.84 and last traded at $33.48. 61,046 shares changed hands during trading, a decline of 83% from the average daily volume of 355,720 shares. The stock had previously closed at $31.56.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the company. Guggenheim reduced their price objective on Septerna from $52.00 to $45.00 and set a “buy” rating for the company in a research report on Wednesday, July 1st. Stifel Nicolaus assumed coverage on Septerna in a research note on Friday, May 1st. They issued a “buy” rating and a $43.00 target price on the stock. Truist Financial upped their price target on shares of Septerna from $35.00 to $43.00 and gave the stock a “buy” rating in a research report on Wednesday, July 1st. Raymond James Financial lifted their price objective on shares of Septerna from $47.00 to $53.00 and gave the company a “strong-buy” rating in a research report on Monday, June 8th. Finally, HC Wainwright restated a “buy” rating and issued a $40.00 target price on shares of Septerna in a research report on Wednesday, July 1st. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Septerna currently has a consensus rating of “Moderate Buy” and a consensus price target of $45.89.

Septerna Stock Up 7.6%

The firm has a market capitalization of $1.53 billion, a P/E ratio of -41.96 and a beta of 2.29. The business’s 50 day moving average is $31.96 and its two-hundred day moving average is $28.07.

Septerna (NASDAQ:SEPN) last released its earnings results on Monday, May 11th. The company reported ($0.19) EPS for the quarter, beating the consensus estimate of ($0.42) by $0.23. The firm had revenue of $26.52 million for the quarter, compared to analysts’ expectations of $16.98 million. Septerna had a negative net margin of 49.88% and a negative return on equity of 12.72%. As a group, equities analysts anticipate that Septerna, Inc. will post -1.59 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Septerna news, insider Samira Shaikhly sold 2,178 shares of the stock in a transaction on Monday, June 29th. The stock was sold at an average price of $35.18, for a total transaction of $76,622.04. Following the completion of the transaction, the insider directly owned 793 shares of the company’s stock, valued at approximately $27,897.74. This trade represents a 73.31% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Daniel D. Long sold 3,333 shares of Septerna stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $34.36, for a total value of $114,521.88. Following the transaction, the senior vice president owned 96,412 shares in the company, valued at approximately $3,312,716.32. This trade represents a 3.34% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 44,494 shares of company stock valued at $1,469,391 over the last 90 days. 5.80% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of SEPN. Goldman Sachs Group Inc. raised its position in Septerna by 86.6% in the fourth quarter. Goldman Sachs Group Inc. now owns 2,715,129 shares of the company’s stock worth $75,698,000 after acquiring an additional 1,260,409 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of Septerna by 7.4% in the 3rd quarter. Vanguard Group Inc. now owns 1,518,757 shares of the company’s stock valued at $28,568,000 after purchasing an additional 104,394 shares during the period. ADAR1 Capital Management LLC increased its stake in Septerna by 38.9% in the 3rd quarter. ADAR1 Capital Management LLC now owns 1,176,491 shares of the company’s stock worth $22,130,000 after purchasing an additional 329,264 shares in the last quarter. Janus Henderson Group PLC acquired a new stake in Septerna during the 1st quarter worth about $21,334,000. Finally, First Light Asset Management LLC lifted its stake in Septerna by 18.0% during the first quarter. First Light Asset Management LLC now owns 732,860 shares of the company’s stock valued at $17,611,000 after buying an additional 112,049 shares in the last quarter.

About Septerna

We are a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by our proprietary Native Complex Platform™. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. GPCRs are the largest and most diverse family of cell membrane receptors and regulate physiological processes in nearly every organ system of the human body.